1304P - Intraperitoneal bevacizumab (Bev) for control of refractory malignant ascites. A single centre experience
| Autor: | Satheesh, C.T., Patil, S., Shashidhara, H.P. |
|---|---|
| Zdroj: | In Annals of Oncology 1 October 2016 27 Supplement 6:vi456-vi456 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|